Ikarian Capital, LLC

Position in VERA — Vera Therapeutics, Inc.

CIK 1778253 DALLAS, TX

Back to VERA Full portfolio

Position in VERA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,302,100

+$5,256,100 QoQ

Shares Held

310,000

+55.0% QoQ

Ownership

0.430%

of shares outstanding

% of Portfolio

2.15%

of 13F equity value

Holder Rank

#42

of 217 holders

Holding Since

Jun 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERA Over Time

Shares Held

Position Value (USD)

Derivatives in VERA

reported options exposure · as of Jun 30, 2026

CallValue

$3,076,647

CallShares

71,700

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. VERA ranks #11 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	328,635	$43,793,900
2	KOD	Kodiak Sciences Inc.	1,059,730	$41,287,080
3	ALMS	Alumis Inc.	870,548	$24,497,220
4	PRAX	Praxis Precision Medicines, Inc.	72,842	$24,386,773
5	PCVX	Vaxcyte, Inc.	388,682	$22,594,084
6	CLDX	Celldex Therapeutics, Inc.	478,500	$17,804,985
7	RCUS	Arcus Biosciences, Inc.	504,559	$15,555,553
8	RLMD	Relmada Therapeutics, Inc.	2,148,359	$14,866,644

All Filings in VERA

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,076,647	71,700	0.0%	Call	Sole	2026-08-14
2026-06-30	$13,302,100	310,000	+55.0%	Shares	Sole	2026-08-14
2026-03-31	$8,046,000	200,000	+1318.8%	Shares	Sole	2026-05-15
2026-03-31	$2,884,491	71,700	-53.2%	Call	Sole	2026-05-15
2025-06-30	$332,101	14,096	—	Shares	Sole	2025-08-14
2025-06-30	$3,609,392	153,200	—	Call	Sole	2025-08-14
No filing history on record for this holder in this stock.